메뉴 건너뛰기




Volumn 127, Issue 1-3, 2002, Pages 245-249

What do we want from proteomics in the detection and avoidance of adverse drug reactions

Author keywords

Adverse drug reactions; Microarrays; Pharmacogenomics; Proteomics

Indexed keywords

FIBRIC ACID DERIVATIVE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST; SEROTONIN UPTAKE INHIBITOR;

EID: 0037186911     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-4274(01)00506-9     Document Type: Conference Paper
Times cited : (20)

References (13)
  • 4
    • 0032494724 scopus 로고    scopus 로고
    • Skin testing in systemic cutaneous drug reactions
    • (1998) Lancet , vol.352 , pp. 1488-1490
    • DeLeo, V.A.1
  • 8
    • 0035977840 scopus 로고    scopus 로고
    • Proteomic profiling from human samples: The body fluid alternative
    • (2001) Toxicol. Lett. , vol.120 , pp. 379-384
    • Kennedy, S.1
  • 11
    • 0034660560 scopus 로고    scopus 로고
    • Pharmacogenetics and the practice of medicine
    • (2000) Nature , vol.405 , pp. 857-865
    • Roses, A.D.1
  • 13
    • 0035865322 scopus 로고    scopus 로고
    • A map of the human genome sequence variation containing 1.42 million single nucleotide polymorphisms
    • (2001) Nature , vol.409 , pp. 928-933


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.